Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing.

Literature DB >> 28483957

Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing.

Maria Emilia Cattana¹, Catiana Dudiuk², Mariana Fernández³, Florencia Rojas³, Liliana Alegre³, Susana Córdoba⁴, Guillermo Garcia-Effron², Gustavo Giusiano³.

Abstract

A total of 59 Candida parapsilosis sensu stricto and 1 Candida orthopsilosis recovered from catheters and blood cultures of pediatric patients from the northeastern region of Argentina were studied. Susceptibility to azoles, amphotericin B, and echinocandins was tested by the broth microdilution method. According to CLSI clinical breakpoints, >91% of the strains were azole susceptible, whereas 15% showed high amphotericin B MICs.

Entities: Chemical Disease Species

Keywords: C. orthopsilosis; C. parapsilosis sensu stricto; PCR-REA; amphotericin B; blood culture; echinocandin

Mesh：

Substances：

Year: 2017 PMID： 28483957 PMCID： PMC5487667 DOI： 10.1128/AAC.02754-16

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

32 in total

1. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors: Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal: Antimicrob Agents Chemother Date: 2011-09-19 Impact factor: 5.191

2. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Authors: A Espinel-Ingroff; M C Arendrup; M A Pfaller; L X Bonfietti; B Bustamante; E Canton; E Chryssanthou; M Cuenca-Estrella; E Dannaoui; A Fothergill; J Fuller; P Gaustad; G M Gonzalez; J Guarro; C Lass-Flörl; S R Lockhart; J F Meis; C B Moore; L Ostrosky-Zeichner; T Pelaez; S R B S Pukinskas; G St-Germain; M W Szeszs; J Turnidge
Journal: Antimicrob Agents Chemother Date: 2013-09-09 Impact factor: 5.191

3. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

Authors: Dominique Sanglard; Françoise Ischer; Michel Monod; Jacques Bille
Journal: Microbiology (Reading) Date: 1997-02 Impact factor: 2.777

4. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors: Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal: J Clin Microbiol Date: 2005-01 Impact factor: 5.948

5. Characterization of Candida parapsilosis complex isolates.

Authors: M de Toro; M J Torres; Ruiz Maite; J Aznar
Journal: Clin Microbiol Infect Date: 2011-03 Impact factor: 8.067

6. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.

Authors: A Gomez-Lopez; A Alastruey-Izquierdo; D Rodriguez; B Almirante; A Pahissa; J L Rodriguez-Tudela; M Cuenca-Estrella
Journal: Antimicrob Agents Chemother Date: 2008-02-19 Impact factor: 5.191

7. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.

Authors: Ana P Silva; Isabel M Miranda; Carmen Lisboa; Cidália Pina-Vaz; Acácio G Rodrigues
Journal: J Clin Microbiol Date: 2009-06-03 Impact factor: 5.948

8. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

Authors: Gloria M González; Rogelio de J Treviño-Rangel; José P Palma-Nicolás; César Martínez; J Gerardo González; Jacobo Ayala; Amílcar Caballero; Rayo Morfín-Otero; E Rodríguez-Noriega; Fernando Velarde; Elba P Ascencio; Juan C Tinoco; Jorge A Vázquez; Manuel A Cano; Nidia León-Sicairos; Rocío González; Joaquín Rincón; Miguel A Elías; Alexandro Bonifaz
Journal: J Antimicrob Chemother Date: 2013-07-18 Impact factor: 5.790

9. New milk medium for germ tube and chlamydoconidia production by Candida albicans.

Authors: S Jitsurong; S Kiamsiri; N Pattararangrong
Journal: Mycopathologia Date: 1993-08 Impact factor: 2.574

10. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors: Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal: Clin Infect Dis Date: 2008-06-15 Impact factor: 9.079

3 in total